Metraipolis › archive › dc_8aa2535e73bf

Development of an adult whole-body PBPK model of irinotecan and its metabolites for predicting UGT1A1/CYP3A-mediated drug-drug interactions — Europe PMC PMID:42272844

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42272844
DOI
10.3389/fphar.2026.1801897
License (as archived)
solo-consultazione
Archived
2026-11-01T06:42:16.846Z
SHA-256 of the archived text
87b0c49b2ab7e7562458f924a0bd36d2b526bb23d0b17bb358c35d42d1f5a96b
Stable URL of this page
https://metraipolis.com/documento/dc_8aa2535e73bf

How to cite

Development of an adult whole-body PBPK model of irinotecan and its metabolites for predicting UGT1A1/CYP3A-mediated drug-drug interactions — Europe PMC PMID:42272844 — Europe PMC (en), https://europepmc.org/article/MED/42272844 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8aa2535e73bf (Metraipolis archive dc_8aa2535e73bf, sha256 87b0c49b2ab7e7562458f924a0bd36d2b526bb23d0b17bb358c35d42d1f5a96b)
BibTeX
@misc{dc8aa2535e73bf,
  title = {Development of an adult whole-body PBPK model of irinotecan and its metabolites for predicting UGT1A1/CYP3A-mediated drug-drug interactions — Europe PMC PMID:42272844},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42272844},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8aa2535e73bf; sha256 87b0c49b2ab7e7562458f924a0bd36d2b526bb23d0b17bb358c35d42d1f5a96b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42272844. Agents can read the archived copy with the MCP tool read_document.